From: Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells
Dex resistant CEM-C1-15 | C | Dex | F | F+Dex | R | R+Dex |
---|---|---|---|---|---|---|
Viable Cells/ml (× 10e5) | 19 | 16 | 7.1 | 1.4 | 3.6 | 1.7 |
Significance (VC/ml, C vs Rx) p = | Â | 0.11 | Â | 0.01 | Â | 0.004 |
% of Drug matched control | Â | 84 | Â | 20 | Â | 47 |
% Culture viability | 99 | 98 | 90 | 38 | 97 | 87 |
Dex sensitive CEM-C7-14 | Â | Â | Â | Â | Â | Â |
Viable Cells/ml (× 10e5) | 14 | 3.2 |  |  |  |  |
Significance (VC/ml, C vs Rx) p = | Â | 0.002 | Â | Â | Â | Â |
% of Drug matched control | Â | 23 | Â | Â | Â | Â |
% Culture viability | 98 | 54 | Â | Â | Â | Â |